Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia and Other Chronic Pain Conditions: A Fourteen-Year, Enterprise-Wide Retrospective Analysis
Biomedicines
As revised 23 March 2023
https://www.mdpi.com/2227-9059/11/4/1087
JanOne to Present Important Trial Results at Annual Meeting of American Society of Interventional Pain Physicians
22 February 2023
https://www.biospace.com/article/releases/janone-to-present-important-trial-results-at-annual-meeting-of-american-society-of-interventional-pain-physicians/
Low-Dose Naltrexone Offers New Hope for Pain Sufferers
Psychology Today
25 April 2022
https://www.psychologytoday.com/us/blog/full-catastrophe-parenting/202204/low-dose-naltrexone-offers-new-hope-pain-sufferers
Low-dose Naltrexone for atopic dermatitis?
National Eczema Association
11 April 2019
https://nationaleczema.org/naltrexone/
Drug relieves chronic pain without the addiction risk
Futurity
17 February 2021
https://www.futurity.org/naltrexone-chronic-pain-addiction-opioids-2519…
A low dose of a drug called naltrexone is a good option for patients with orofacial and chronic pain, without the risk of addiction, researchers report.
Comments on "Low-Dose Naltrexone Use for Patients with Chronic Regional Pain Syndrome: A Systematic Literature Review"
Pain Physician
December 2021
https://www.painphysicianjournal.com/current/pdf?article=NzM4NA%3D%3D
In Response Comments on "Low-Dose Naltrexone Use for Patients with Chronic Regional Pain Syndrome: A Systematic Literature Review"
Pain Physician
December 2021
https://www.painphysicianjournal.com/current/pdf?article=NzM4NQ%3D%3D
Pradeep Chopra, MD - Chronic Pain, Opioids and LDN (2016 Conference) (LDN, low dose naltrexone)
Darin Ingels, ND - LDN and Children (2017 Conference) (LDN, low dose naltrexone)
Research on LDN in children shows it is safe with low side effects. Studies where LDN was used successfully in children: 2 with Crohn’s, 2 with autism, 1 with CRPS. His cases: autism; Hashimoto’s; IBS.